Jason Baumgartner of BEKhealth Corporation Talks About The Current State of Research Operations in a COVID World with TrialSite
Jason CEO of BEKhealth Corporation talks with TrialSite about the current state of research operations in a COVID world. How COVID has impacted researcher capacity. How technology is improving patient pre-screening and enrollment. How sites can implement new technologies to alleviate manual processes and see more patients.
Read More
Can AI Help You Recruit for Your Patient-Centered Clinical Trials?
Patient-centered clinical trials place the participant at the heart of the study process. It seems crazy to think that this has not always been the case – after all, without patients there can be no clinical trials, no data to comb through, and no new discoveries....
The New Patient Recruitment – AI to Identify Patients and AI to Action Patients Into the Recruitment Process
In our previous blogs, we’ve written a lot about how artificial intelligence (AI) can, and already is, transforming patient recruitment for clinical trials. And it’s true – that’s why we’ve built the BEKplatform. But while advanced AI technologies help identify...
How Does AI Accelerate Clinical Trial Recruitment?
The journey from discovery to delivery of a new drug is long and complex, often spanning many years and costing millions of dollars. Patient recruitment and enrollment weigh heavily in determining how quickly a study can get started, and the success of a clinical...
Bridging the Gap: How AI is Leveling the Playing Field Between Large and Small Pharma
In our last blog, we discussed how a recent report by PPD showed growing optimism from within the pharmaceutical industry around our ability to solve core clinical research challenges related to patient recruitment, spurred by the advance of technologies like...